Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Teppo

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|June 22, 2000
Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995T Milán, E Pukkala, P K Verkasalo, et al.
Scandinavian Journal of Work, Environment & Health|August 18, 1999
Cancer incidence among European man-made vitreous fiber production workersP Boffetta, A Andersen, J Hansen, et al.
Cancer|March 15, 1993
Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screeningJ Järvisalo, M Hakama, P Knekt, et al.
Journal of Medical Virology|February 1, 1989
Lack of serum antibodies to the major HSV-2 specified DNA-binding protein before diagnosis of cervical neoplasiaM Lehtinen, M Hakama, P Knekt, et al.
American Journal of Epidemiology|January 15, 1993
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-upM Hakama, M Lehtinen, P Knekt, et al.
The American Journal of Clinical Nutrition|January 1, 1991
Vitamin E and cancer preventionP Knekt, A Aromaa, J Maatela, et al.
Lancet (London, England)|August 20, 1977
Thalidomide-type malformations and subsequent osteosarcomaL Teppo, E Saxén, T Tervo, et al.
American Journal of Epidemiology|July 15, 1996
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancerA Aromaa, T U Kosunen, P Knekt, et al.
Journal of Internal Medicine|January 1, 1994
The Helsinki Heart Study: an 8.5-year safety and mortality follow-upJ K Huttunen, O P Heinonen, V Manninen, et al.
American Journal of Epidemiology|August 15, 1991
Serum micronutrients and risk of cancers of low incidence in FinlandP Knekt, A Aromaa, J Maatela, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|June 22, 2000
Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995T Milán, E Pukkala, P K Verkasalo, et al.
Scandinavian Journal of Work, Environment & Health|August 18, 1999
Cancer incidence among European man-made vitreous fiber production workersP Boffetta, A Andersen, J Hansen, et al.
Cancer|March 15, 1993
Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screeningJ Järvisalo, M Hakama, P Knekt, et al.
Journal of Medical Virology|February 1, 1989
Lack of serum antibodies to the major HSV-2 specified DNA-binding protein before diagnosis of cervical neoplasiaM Lehtinen, M Hakama, P Knekt, et al.
American Journal of Epidemiology|January 15, 1993
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-upM Hakama, M Lehtinen, P Knekt, et al.
The American Journal of Clinical Nutrition|January 1, 1991
Vitamin E and cancer preventionP Knekt, A Aromaa, J Maatela, et al.
Lancet (London, England)|August 20, 1977
Thalidomide-type malformations and subsequent osteosarcomaL Teppo, E Saxén, T Tervo, et al.
American Journal of Epidemiology|July 15, 1996
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancerA Aromaa, T U Kosunen, P Knekt, et al.
Journal of Internal Medicine|January 1, 1994
The Helsinki Heart Study: an 8.5-year safety and mortality follow-upJ K Huttunen, O P Heinonen, V Manninen, et al.
American Journal of Epidemiology|August 15, 1991
Serum micronutrients and risk of cancers of low incidence in FinlandP Knekt, A Aromaa, J Maatela, et al.
Pageof 15